PATENT CLAIM ANALYSIS

Application Number: 15976333
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides oligonucleotide inhibitors of miR-155 and compositions thereof. The invention further provides methods for treating cancer such as a T cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of miR-155. The invention also provides methods for reducing or inhibiting the proliferation of malignant T cells by administering an oligonucleotide inhibitor of miR-155.

Claim (Index 85):
The method of  claim 84 , wherein the CTCL is mycosis fungoides (MF) sub-type.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.65789
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15173368', '15714671', '15878176', '13327507', '15154711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8174961113493063
- 35 USC 102 Novelty (BERT): 0.6588657233322693
- Combined Prediction Score: 0.8016330725476026
- Mean Citation Score: 538.1526719999998
- Max Citation Score: 756.5612
- Similarity Product: 579.5655869456291

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test